Trials / Completed
CompletedNCT00883727
Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI
A Randomized, Double Blind, Multicentric, Placebo Controlled, Single Dose, Phase - i/ii Study Assessing the Safety and Efficacy of Intravenous ex Vivo Cultured Adult Allogenic Mesenchymal Stem Cells in Patients With st Elevated Acute Myocardial Infarction (Stemi)
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Stempeutics Research Pvt Ltd · Industry
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial aims to find out the safety and efficacy of adult mesenchymal stem cells in patients with myocardial infarction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Stem cell | IV infusion of stem cells |
| DRUG | Plasmalyte A | IV infusion |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2010-05-01
- Completion
- 2012-08-01
- First posted
- 2009-04-20
- Last updated
- 2013-03-05
Locations
4 sites across 1 country: India
Source: ClinicalTrials.gov record NCT00883727. Inclusion in this directory is not an endorsement.